Company BRAIN Biotech AG

Equities

BNN

DE0005203947

Environmental Services & Equipment

Market Closed - Xetra Other stock markets 11:36:22 2025-01-17 am EST			5-day change	1st Jan Change
3.310 ^EUR	+1.85%		-4.89%	-6.76%

Jan. 14	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	CI
Dec. 12	BRAIN Biotech AG - Analyst/Investor Day

Business description: BRAIN Biotech AG

BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.

Number of employees: 318

Sales by Activity: BRAIN Biotech AG

Fiscal Period: September	2020	2021	2022	2023	2024
Bioproducts	25.23M	28.3M	37.7M	42.64M	42.64M
Bioscience (excl. Bioincubator)	-	-	-	12.68M	11.1M
Bio Science	13.92M	11.08M	12.71M	-	-
Bioincubator	-	-	-	944K	2.05M
Reconciliation	-86K	-159K	-118K	-39K	-286K

See all business segments

Geographical breakdown of sales: BRAIN Biotech AG

Fiscal Period: September	2020	2021	2022	2023	2024
Other Abroad	12.96M	10.7M	13.58M	16.47M	16.58M
USA	6.88M	8.86M	14.02M	15.31M	13.51M
Netherlands	-	4.98M	6.54M	10.38M	11.28M
Germany	8.9M	7.07M	7.93M	5.66M	6.65M
United Kingdom	4.53M	3.7M	3.64M	4.77M	3.68M
France	4.95M	3.08M	3.8M	2.74M	2.92M

See all geographic segments

Managers: BRAIN Biotech AG

Director	Title	Age	Since
Michael Schneider DFI	Director of Finance/CFO	55	2022-09-30
Alexander Pelzer CTO	Chief Tech/Sci/R&D Officer	39	2022-12-31
Martina Schuster IRC	Investor Relations Contact	-	-
Ute Dechert ADM	Chief Administrative Officer	64	2000-12-31
Martin Langer PRN	Corporate Officer/Principal	60	-

See BRAIN BIOTECH AG governance

Members of the board: BRAIN Biotech AG

Manager	Title	Age	Since
Anna Carina Eichhorn BRD	Director/Board Member	53	2017-03-08
Michael Majerus CHM	Chairman	63	2023-03-07
Stephen Catling BRD	Director/Board Member	60	2020-10-13
Christine Uekert BRD	Director/Board Member	61	2023-03-07
Florian Schnabel BRD	Director/Board Member	55	2023-03-07

Composition of the Board of Directors

Shareholders: BRAIN Biotech AG

Name	Equities	%	Valuation
Martin Putsch 45.40 %	9,918,763	45.40 %	37 M €
Daniel Hopp 5.600 %	1,223,460	5.600 %	5 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 4.988 %	1,089,743	4.988 %	4 M €
Gabriele Sachse 2.723 %	595,000	2.723 %	2 M €
Apo Asset Management GmbH 2.254 %	492,370	2.254 %	2 M €

List of BRAIN BIOTECH AG shareholders

Company details: BRAIN Biotech AG

BRAIN Biotech AG

Darmstädter Strasse 34-36

64673, Zwingenberg

+49 62 51 9331 0

http://www.brain-biotech.de

Environmental Biotechnology

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
BRAIN BIOTECH AG	+1.85%	-4.89%	-18.27%	-66.50%	74.42M
AVANTIUM N.V.	+0.44%	+0.44%	-48.35%	-61.73%	161M
Average	+1.14%	-2.22%	-33.31%	-64.11%	117.79M
Weighted average by Cap.	+0.89%	-1.24%	-38.85%	-63.23%